Orasure Technologies Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−3.61%
vs ±22.6% implied · ×0.16
shaded = implied · ▲▼ = realized
Linked news
SentencePursuant to a strategic agreement with Diagnostics Direct, the Company distributes the Syphilis Health Check ™ rapid diagnostic test.
OSUR 10-Kaccession 0001116463-26-000016
SentenceThe Company also licenses the SHERLOCK™ mark from The Broad Table of Contents Institute, Inc.
OSUR 10-Kaccession 0001116463-26-000016
SentenceIn September 2022, the Company entered into an $8.6 million contract with BARDA to develop an updated Ebola test on the OraQuick ® testing platform, which was subsequently modified in September 2023 to add an additional $6.8 in funding to be used to obtain the appropriate regulatory approvals.
OSUR 10-Kaccession 0001116463-26-000016
SentenceAlso in September, 2022, the Company was selected to provide its OraQuick ® HIV Self-Tests in support of the CDC "Together Take me Home," HIV self-test program.
OSUR 10-Kaccession 0001116463-26-000016
SentenceHistorically, the Company has sold a number of its products to the government under contracts with the General Services Administration and the Veterans Administration.
OSUR 10-Kaccession 0001116463-26-000016
SentenceFor example, in January 2024, the Company announced its investment and entry into wide ranging strategic distribution agreements with KKR Sapphiros L.P. ("Sapphiros"), in December 2024, the Company acquired Sherlock, expanding the Company's product pipeline with the addition of Sherlock's molecular diagnostics platform, and in November 2025, the Company acquired BioMedomics, also expanding the Company's product pipeline with the addition of BioMedomics' SickleSCAN™ test for sickle cell disease.
OSUR 10-Kaccession 0001116463-26-000016
SentenceThrough 2025, the Company maintained its expanded United States production capacity for InteliSwab ® tests to meet capacity targets set out in its 2021 contract with the U.S. Department of Defense ("DOD") (in coordination with the U.S. Department of Health and Human Services ("HHS")), of more than 100 million tests annually.
OSUR 10-Kaccession 0001116463-26-000016
SentenceHistorically, the Company has sold a number of its products to the government under contracts with the General Services Administration and the Veterans Administration.
OSUR 10-Kaccession 0001116463-26-000016
Orasure Technologies has 2 disclosed suppliers and 8 disclosed customers in SEC filings.
Orasure Technologies Inc
3.95
Expected move
No implied move.